ArriVent BioPharma Balance Sheet (2023-2026) | AVBP

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter) 124.30M317.39M298.67M282.86M74.29M49.87M112.77M305.40M45.54M62.10M
Prepaid Assets (Quarter) 0.13M7.76M9.84M7.90M8.12M0.92M13.17M0.45M0.06M20.83M
Current Assets (Quarter) 159.97M327.48M308.51M292.40M226.98M185.78M250.15M321.22M332.90M348.70M
Non-Current Assets
Long-Term Investments (Quarter) 47.68M29.41M18.79M5.11M
Long-Term Deferred Tax (Quarter) 2.73M0.07M0.07M
Other Non-Current Assets (Quarter) 0.11M0.11M0.12M0.13M0.13M0.18M0.48M0.18M0.19M0.16M
Non-Current Assets (Quarter) 3.13M0.36M0.34M0.31M47.96M29.71M19.36M5.34M0.27M0.59M
Assets (Quarter) 163.10M327.84M308.86M292.71M274.94M215.50M269.51M326.56M333.17M349.30M
Liabilities
Current Liabilities
Accounts Payables (Quarter) 4.53M4.10M3.81M4.65M3.78M4.36M4.06M5.93M5.93M8.73M
Payables (Quarter) 4.53M4.10M3.81M4.65M3.78M4.36M4.06M5.93M5.93M8.73M
Accumulated Expenses (Quarter) 3.35M5.73M2.04M6.83M4.16M1.55M15.48M10.82M20.00M16.17M
Other Accumulated Expenses (Quarter) 0.06M0.04M0.12M0.14M0.07M0.16M0.16M0.10M0.02M0.04M
Current Leases (Quarter) 0.14M0.15M0.15M0.16M0.16M0.14M0.10M0.06M0.01M0.10M
Total Current Liabilities (Quarter) 11.62M9.98M12.10M15.16M17.27M12.95M19.64M21.56M25.95M25.00M
Non-Current Liabilities
Preferred Stock Liabilities (Quarter) 149.87M154.62M149.87M149.87M
Operating Leases (Quarter) 0.18M0.14M0.10M0.06M0.01M0.32M
Total Liabilities (Quarter) 11.80M10.12M12.20M15.22M17.29M12.95M19.64M21.56M25.95M25.32M
Shareholder's Equity
Common Equity (Quarter) -97.09M-118.46M-132.60M-153.19M317.72M296.66M277.49M257.65M202.54M249.87M305.00M307.22M323.98M
Liabilities and Shareholders Equity (Quarter) 163.10M327.84M308.86M292.71M274.94M215.50M269.51M326.56M333.17M349.30M
Retained Earnings (Quarter) 4.65M-175.26M-197.10M495.19M496.19M-302.70M-334.12M-369.10M0.01M772.21M
Treasury Shares (Quarter) 150.00M